Cited by — A Nitric Oxide–Based STING Agonist Nanoadjuvant With ICD‐Derived Membrane Antigens Unleashes Robust Antitumor Immunity | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite A Nitric Oxide–Based STING Agonist Nanoadjuvant With ICD‐Derived Membrane Antigens Unleashes Robust Antitumor Immunity.
No admitted local citation edges point to this work yet.
